What is a stock summary page? Click here for an overview.
Business Description
Yuyu Pharma Inc
SIC : 2836
ISIN : KR7000220004
Compare
Compare
Traded in other countries / regions
000220.Korea Index Membership
KOSPI IPO Date
1975-11-18Description
Yuyu Pharma Inc. manufactures and markets medicines. The product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.27 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 1.78 | |||||
| Interest Coverage | 3.91 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.84 | |||||
| Beneish M-Score | -3.08 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.5 | |||||
| 3-Year EBITDA Growth Rate | 36.9 | |||||
| 3-Year Book Growth Rate | 0.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.28 | |||||
| 9-Day RSI | 28.75 | |||||
| 14-Day RSI | 34.46 | |||||
| 3-1 Month Momentum % | 6.76 | |||||
| 6-1 Month Momentum % | 2.6 | |||||
| 12-1 Month Momentum % | -8.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.58 | |||||
| Quick Ratio | 0.98 | |||||
| Cash Ratio | 0.66 | |||||
| Days Inventory | 189.74 | |||||
| Days Sales Outstanding | 52.32 | |||||
| Days Payable | 40.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.27 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| 3-Year Dividend Growth Rate | -1.6 | |||||
| Forward Dividend Yield % | 2.27 | |||||
| 5-Year Yield-on-Cost % | 2.27 | |||||
| 3-Year Average Share Buyback Ratio | 0.6 | |||||
| Shareholder Yield % | 11.97 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.83 | |||||
| Operating Margin % | 9.45 | |||||
| Net Margin % | 6.55 | |||||
| FCF Margin % | 13.25 | |||||
| ROE % | 7.33 | |||||
| ROA % | 4.35 | |||||
| ROIC % | 8.75 | |||||
| 3-Year ROIIC % | 42.69 | |||||
| ROC (Joel Greenblatt) % | 11.03 | |||||
| ROCE % | 9.17 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.54 | |||||
| PE Ratio without NRI | 8.95 | |||||
| Price-to-Owner-Earnings | 7.93 | |||||
| PS Ratio | 0.61 | |||||
| PB Ratio | 0.59 | |||||
| Price-to-Tangible-Book | 0.6 | |||||
| Price-to-Free-Cash-Flow | 4.46 | |||||
| Price-to-Operating-Cash-Flow | 3.22 | |||||
| EV-to-EBIT | 5.68 | |||||
| EV-to-EBITDA | 3.97 | |||||
| EV-to-Revenue | 0.56 | |||||
| EV-to-FCF | 4.26 | |||||
| Price-to-GF-Value | 0.92 | |||||
| Price-to-Projected-FCF | 1.4 | |||||
| Price-to-Median-PS-Value | 0.68 | |||||
| Price-to-Graham-Number | 0.49 | |||||
| Price-to-Net-Current-Asset-Value | 4.23 | |||||
| Earnings Yield (Greenblatt) % | 17.61 | |||||
| FCF Yield % | 24.67 | |||||
| Forward Rate of Return (Yacktman) % | -18.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Yuyu Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 133,147.218 | ||
| EPS (TTM) (â‚©) | 459 | ||
| Beta | 0.67 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -0.9 | ||
| Volatility % | 21.1 | ||
| 14-Day RSI | 34.46 | ||
| 14-Day ATR (â‚©) | 107.227441 | ||
| 20-Day SMA (â‚©) | 4517 | ||
| 12-1 Month Momentum % | -8.67 | ||
| 52-Week Range (â‚©) | 3900 - 5590 | ||
| Shares Outstanding (Mil) | 16.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Yuyu Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Yuyu Pharma Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Yuyu Pharma Inc Frequently Asked Questions
What is Yuyu Pharma Inc(XKRX:000220)'s stock price today?
The current price of XKRX:000220 is â‚©4375.00. The 52 week high of XKRX:000220 is â‚©5590.00 and 52 week low is â‚©3900.00.
When is next earnings date of Yuyu Pharma Inc(XKRX:000220)?
The next earnings date of Yuyu Pharma Inc(XKRX:000220) is 2025-05-16 Est..
Does Yuyu Pharma Inc(XKRX:000220) pay dividends? If so, how much?
The Dividend Yield %  of Yuyu Pharma Inc(XKRX:000220) is 2.27% (As of Today), Highest Dividend Payout Ratio of Yuyu Pharma Inc(XKRX:000220) was 2.53. The lowest was 0.19. And the median was 0.32. The  Forward Dividend Yield % of Yuyu Pharma Inc(XKRX:000220) is 2.27%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers